Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Syndecan-1 ELISA Kit (AC3060)
Cat.#: ASET-1649
Specifications
Description Rat Syndecan-1 ELISA Kit allows for the in vitro quantitative determination of rat Syndecan-1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.938 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.563-100 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2415 Mouse Substance P ELISA Kit (AC3826) Quantitative inquiry ASET-1516 Human NG2 ELISA Kit (AC2927) Quantitative inquiry ASET-2312 Human Pannexin 1 ELISA Kit (AC3723) Quantitative inquiry ASET-1607 Human Glutamine Synthetase ELISA Kit (AC3018) Quantitative inquiry ASET-2391 Human CRF ELISA Kit (AC3802) Quantitative inquiry ASET-1312 Bovine Adiponectin ELISA Kit (AC2723) Quantitative inquiry ASET-1730 Human Caspase-12 ELISA Kit (AC3141) Quantitative inquiry ASET-1115 Human AVPR1B ELISA Kit (AC2526) Quantitative inquiry ASET-1830 Human Oxytocin ELISA Kit (AC3241) Quantitative inquiry ASET-2001 Human BCS1L ELISA Kit (AC3412) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket